bullybeef
Senior Member
- Messages
- 488
- Location
- North West, England, UK
This is old news, but I believe it maybe highly relevant, and I couldn't find any previous mention of it.
See: http://www.sciencedaily.com/releases/2003/06/030613074858.htm
See: http://www.nytimes.com/2003/06/13/us/cancer-risk-exceeds-outlook-in-gene-therapy-studies-find.html
See: http://www.sciencedaily.com/releases/2003/06/030613074858.htm
Among the most widely used in gene therapy studies is the Moloney murine Leukemia Virus (MoMuLV), a mouse retrovirus that also can infect human cells. Physicians now believe that the children in the French study developed leukemia because the MoMuLV inserted therapeutic genes next to a gene known to promote blood cancer.
See: http://www.nytimes.com/2003/06/13/us/cancer-risk-exceeds-outlook-in-gene-therapy-studies-find.html
In the study being published today, in the journal Science, Dr. Shawn M. Burgess and colleagues at the National Human Genome Research Institute looked at 903 cases in which murine leukemia viruses, very similar to the type used in the French gene therapy, infected human cells in culture.